An open label single centre phase-I study to evaluate safety, reactogenicity and immunogenicity of a single intramuscular dose of an inactivated poliomyelitis vaccine of Biological E Limited in 18-45 year old healthy adults. - None
Latest Information Update: 21 Jan 2020
At a glance
- Drugs Poliovirus vaccine inactivated (Primary)
- Indications Poliomyelitis
- Focus Adverse reactions
- Sponsors Biological E Limited
- 10 Jan 2020 Status changed from recruiting to active, no longer recruiting.
- 26 Sep 2019 New trial record